Immunic, Inc.
Hedge Funds Holdings
Last updated:
Immunic, Inc.‘s stocks are currently a part of 33 hedge funds’ portfolios, which represents 32.04% of the total amount of its stocks outstanding. This makes up a total of 10.19M shares of Immunic, Inc.. Compared to the previous quarter, the number fell by -59.07% or -14.71M shares fewer. As for the holding position changes, 15.15% (5) of current hedge fund investors increased the number of shares held, 27.27% (9) of current holders sold a part of the shares held, and 9.09% (3) closed the holdings completely. 6 hedge funds are new holders of Immunic, Inc. stock in Q1 2023, it is 18.18% of total holders.
Hedge funds holding Immunic (Q2 2019 – Q1 2023)
Q2 2019 | 22 |
---|---|
Q3 2019 | 19 |
Q4 2019 | 15 |
Q1 2020 | 16 |
Q2 2020 | 49 |
Q3 2020 | 67 |
Q4 2020 | 69 |
Q1 2021 | 62 |
Q2 2021 | 58 |
Q3 2021 | 67 |
Q4 2021 | 66 |
Q1 2022 | 78 |
Q2 2022 | 67 |
Q3 2022 | 63 |
Q4 2022 | 62 |
Q1 2023 | 33 |
Hedge funds changes in Immunic positions (Q2 2019 – Q1 2023)
Q2 2019 | 22 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q3 2019 | 4 | 3 | 7 | 7 | -2 |
Q4 2019 | 3 | 4 | 3 | 7 | -2 |
Q1 2020 | 3 | 4 | 2 | 2 | 5 |
Q2 2020 | 35 | 8 | 4 | 2 | 0 |
Q3 2020 | 30 | 25 | 8 | 11 | -7 |
Q4 2020 | 12 | 28 | 15 | 9 | 5 |
Q1 2021 | 8 | 17 | 22 | 14 | 1 |
Q2 2021 | 5 | 29 | 10 | 9 | 5 |
Q3 2021 | 13 | 31 | 11 | 4 | 8 |
Q4 2021 | 12 | 27 | 15 | 13 | -1 |
Q1 2022 | 17 | 20 | 28 | 5 | 8 |
Q2 2022 | 16 | 16 | 23 | 25 | -13 |
Q3 2022 | 10 | 17 | 20 | 15 | 1 |
Q4 2022 | 21 | 23 | 13 | 21 | -16 |
Q1 2023 | 6 | 5 | 9 | 3 | 10 |
Hedge funds changes in Immunic stock options (Q2 2019 – Q1 2023)
Q2 2019 | 4,622,000 | 275,000 |
---|---|---|
Q3 2019 | 2,775,000 | 0 |
Q4 2019 | 2,672,000 | 0 |
Q1 2020 | 333,000 | 0 |
Q2 2020 | 676,000 | 0 |
Q3 2020 | 2,221,000 | 625,000 |
Q4 2020 | 2,580,000 | 323,000 |
Q1 2021 | 1,514,000 | 927,000 |
Q2 2021 | 1,242,000 | 1,013,000 |
Q3 2021 | 763,000 | 194,000 |
Q4 2021 | 774,000 | 143,000 |
Q1 2022 | 12,682,000 | 8,875,000 |
Q2 2022 | 3,661,000 | 2,557,000 |
Q3 2022 | 1,374,000 | 300,000 |
Q4 2022 | 738,100 | 521,400 |
Q1 2023 | 32,649,000 | 25,024,000 |